Status of Cancer Care at Network Sites of the Nation’s Academic Cancer Centers
| Autor: | Carrie B. Lee, Lois Teston, Laura F. Hutchins, Louis M. Weiner, Kate Shaw, Louis B. Harrison, Daniel Mulkerin, Randall F. Holcombe, Patrick J. Loehrer, Stanton L. Gerson, George J. Weiner, W. Thomas Purcell |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Certification media_common.quotation_subject MEDLINE Pharmacy Survey result Article 03 medical and health sciences 0302 clinical medicine Neoplasms Physicians Surveys and Questionnaires Electronic Health Records Humans Patient Navigation Medicine Quality (business) 030212 general & internal medicine media_common business.industry Medical record Cancer medicine.disease United States Clinical trial Oncology 030220 oncology & carcinogenesis Family medicine business |
| Zdroj: | J Natl Compr Canc Netw |
| ISSN: | 1540-1413 1540-1405 |
| DOI: | 10.6004/jnccn.2020.7656 |
| Popis: | Background: Cancer care coordination across major academic medical centers and their networks is evolving rapidly, but the spectrum of organizational efforts has not been described. We conducted a mixed-methods survey of leading cancer centers and their networks to document care coordination and identify opportunities to improve geographically dispersed care. Methods: A mixed-methods survey was sent to 91 cancer centers in the United States and Canada. We analyzed the number and locations of network sites; access to electronic medical records (EMRs); clinical research support and participation at networks; use of patient navigators, care paths, and quality measures; and physician workforce. Responses were collected via Qualtrics software between September 2017 and December 2018. Results: Of the 69 responding cancer centers, 74% were NCI-designated. Eighty-seven percent of respondents were part of a matrix health system, and 13% were freestanding. Fifty-six reported having network sites. Forty-three respondents use navigators for disease-specific populations, and 24 use them for all patients. Thirty-five respondents use ≥1 types of care path. Fifty-seven percent of networks had complete, integrated access to their main center’s EMRs. Thirty-nine respondents said the main center provides funding for clinical research at networks, with 22 reporting the main center provides all funding. Thirty-five said the main center provided pharmacy support at the networks, with 15 indicating the main center provides 100% pharmacy support. Certification program participation varied extensively across networks. Conclusions: The data show academic cancer centers have extensive involvement in network cancer care, often extending into rural communities. Coordinating care through improved clinical trial access and greater use of patient navigation, care paths, coordinated EMRs, and quality measures is likely to improve patient outcomes. Although it is premature to draw firm conclusions, the survey results are appropriate for mapping next steps and data queries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|